Sulog, Nurshaina T.

HRN: 23-35-56  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
07/17/2023
07/24/2023
TOPICAL
1%
BID
2nd Degree Partial Thickness Burn
Waiting Final Action 
07/17/2023
CEFUROXIME 750MG (VIAL)
07/17/2023
07/24/2023
IV
234mg
Q8H
2nd Degree Burn 31.5%
Waiting Final Action 
07/19/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
07/19/2023
07/26/2023
TOPICAL
1%
BID
Scald Burns
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: